Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PRA Health Sciences Inc. PRAH

Healthcare Diagnostics & Research
PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In... see more

Recent & Breaking News (NDAQ:PRAH)

PRA Health Sciences and Jumo Announce Partnership

GlobeNewswire June 19, 2017

Healthcare Stocks on Investors' Radar -- PAREXEL, IDEXX Labs, ICON PLC, and PRA Health Sciences

PR Newswire June 9, 2017

PRA Health Sciences Named International Clinical Research Company of the Year

GlobeNewswire May 22, 2017

DelMar Formalizes Collaboration with PRA Health Sciences for Phase 3 Trial of VAL-083 in Recurrent Glioblastoma Multiforme (GBM)

PR Newswire May 11, 2017

PRA Health Sciences Announces The Center for Pediatric Clinical Development

GlobeNewswire May 4, 2017

PRA Health Sciences Named Clinical Research Company of the Year

GlobeNewswire May 2, 2017

Research Reports Initiation on Medical Research Stocks -- Alere, OpGen, Novadaq Technologies, and PRA Health

PR Newswire April 26, 2017

PRA Health Sciences, Inc. Reports First Quarter 2017 Results

GlobeNewswire April 25, 2017

PRA Health Sciences to Report First Quarter 2017 Earnings

GlobeNewswire April 17, 2017

PRA Health Sciences Named Top Workplace in Philadelphia

GlobeNewswire March 27, 2017

How These Medical Laboratories Stocks are Faring? -- PAREXEL, Novadaq Technologies, Charles River Laboratories, and PRA Health Sciences

PR Newswire March 7, 2017

PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2016 Results and Provides Q1 and Full Year 2017 Guidance

GlobeNewswire February 22, 2017

PRA Health Sciences to Report Fourth Quarter 2016 Earnings and Issue 2017 Guidance

GlobeNewswire February 2, 2017

Research Reports Initiation on Healthcare Stocks -- PAREXEL, Charles River Laboratories, PRA Health Sciences, and Invitae

PR Newswire January 19, 2017

Medical Laboratories & Research Stocks on Investors' Radar -- Quintiles IMS, PAREXEL, Charles River Laboratories, and PRA Health Sciences

PR Newswire December 9, 2016

PRA Health Sciences, Inc. Announces Secondary Offering of 7,500,000 Shares of Common Stock

GlobeNewswire November 10, 2016

PRA Health Sciences, Inc. Reports Third Quarter 2016 Results and Updates 2016 Guidance

GlobeNewswire November 2, 2016

Research Reports Initiation on Healthcare Stocks -- Quintiles IMS, PRA Health Sciences, BioTelemetry, and OpGen

PR Newswire November 2, 2016

PRA Health Sciences to Report Third Quarter 2016 Earnings

GlobeNewswire October 10, 2016

Takeda and PRA Health Sciences Announce Transformational Clinical Development and Marketed Product Partnership

Business Wire September 12, 2016